A novel method for the immunoquantification of UDP-glucuronosyltransferases in human tissue

Drug Metabolism and Disposition

Volumn 39, Issue 12, 2011, Pages 2258-2263

  Milne, Alison M ^a   Burchell, Brian ^a   Coughtrie, Michael W H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; HYBRID PROTEIN; RIBONUCLEASE; RIBONUCLEASE S PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CYTOPLASM; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY MICROSOME; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; GLUCURONOSYLTRANSFERASE; HUMANS; ISOENZYMES; POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI;

EID: 81855206614     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.041699     Document Type: Article

References (39)

1. Aueviriyavit S, Furihata T, Morimoto K, Kobayashi K, and Chiba K (2007) Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers. Drug Metab Pharmacokinet 22:391-398.
2. Benoit-Biancamano MO, Connelly J, Villeneuve L, Caron P, and Guillemette C (2009) Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Drug Metab Dispos 37:322-329.
3. Better M, Chang CP, Robinson RR, and Horwitz AH (1988) Escherichia coli secretion of an active chimeric antibody fragment. Science 240:1041-1043.
4. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, and Oude Elferink RP (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171-1175.
5. Burchell B and Coughtrie MW (1989) UDP-glucuronosyltransferases. Pharmacol Ther 43:261-289. (Pubitemid 19201287)
6. Chen Y, Kuehl GE, Bigler J, Rimorin CF, Schwarz Y, Shen DD, and Lampe JW (2007) UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin. Pharmacogenet Genomics 17:571-579. (Pubitemid 47057706)
7. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, and Mackenzie PI (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998-1006. (Pubitemid 33104971)
8. Ethell BT, Anderson GD, Beaumont K, Rance DJ, and Burchell B (1998) A universal radiochemical high-performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity. Anal Biochem 255:142-147. (Pubitemid 28047630)
9. Ethell BT, Anderson GD, and Burchell B (2003) The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP- glucuronosyltransferases. Biochem Pharmacol 65:1441-1449. (Pubitemid 36555832)
10. Fallon JK, Harbourt DE, Maleki SH, Kessler FK, Ritter JK, and Smith PC (2008) Absolute quantification of human uridine-diphosphate glucuronosyl transferase (UGT) enzyme isoforms 1A1 and 1A6 by tandem LC-MS. Drug Metab Lett 2:210-222.
11. Gerber SA, Rush J, Stemman O, Kirschner MW, and Gygi SP (2003) Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci USA 100:6940-6945. (Pubitemid 36706372)
12. Heirwegh KP, Van de Vijver M, and Fevery J (1972) Assay properties of digitonin-activated bilirubin uridine diphosphate glucuronyltransferase from rat liver. Biochem J 129:605-618.
13. Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, and McLeod HL (2007) UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 99:1290-1295. (Pubitemid 47394168)
14. Izukawa T, Nakajima M, Fujiwara R, Yamanaka H, Fukami T, Takamiya M, Aoki Y, Ikushiro S, Sakaki T, and Yokoi T (2009) Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 37:1759-1768.
15. Kettenbach AN, Rush J, and Gerber SA (2011) Absolute quantification of protein and posttranslational modification abundance with stable isotope-labeled synthetic peptides. Nat Protoc 6:175-186.
16. Kim JS and Raines RT (1993) Ribonuclease S-peptide as a carrier in fusion proteins. Protein Sci 2:348-356.
17. Koiwai O, Nishizawa M, Hasada K, Aono S, Adachi Y, Mamiya N, and Sato H (1995) Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet 4:1183-1186.
18. Krishnaswamy S, Hao Q, Al-Rohaimi A, Hesse LM, von Moltke LL, Greenblatt DJ, and Court MH (2005) UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5′-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation. J Pharmacol Exp Ther 313:1331-1339. (Pubitemid 40727039)
19. Krishnaswamy S, Hao Q, Von Moltke LL, Greenblatt DJ, and Court MH (2004) Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6. Drug Metab Dispos 32:862-869. (Pubitemid 38955616)
20. Lankisch TO, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, and Strassburg CP (2006) Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Hepatology 44:1324-1332. (Pubitemid 44748383)
21. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
22. Monaghan G, Ryan M, Seddon R, Hume R, and Burchell B (1996) Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 347:578-581. (Pubitemid 26070740)
23. Nagar S and Remmel RP (2006) Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 25:1659-1672.
24. Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
25. Ouzzine M, Fournel-Gigleux S, Pillot T, Burchell B, Siest G, and Magdalou J (1994) Expression of the human UDP-glucuronosyltransferase UGT1*6 in Escherichia coli. Influence of bacterial signal peptides on the production and localization of the recombinant protein. FEBS Lett 339:195-199.
26. Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, and Zeldin DC (2006) The human intestinal cytochrome P450 "pie." Drug Metab Dispos 34:880-886.
27. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, and Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329:15-19. (Pubitemid 38869995)
28. Riches Z, Bloomer J, Patel A, Nolan A, and Coughtrie M (2009a) Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation. Xenobiotica 39:374-381.
29. Riches Z, Bloomer JC, and Coughtrie MW (2007) Comparison of 2-aminophenol and 4-nitrophenol as in vitro probe substrates for the major human hepatic sulfotransferase, SULT1A1, demonstrates improved selectivity with 2-aminophenol. Biochem Pharmacol 74:352-358. (Pubitemid 46890815)
30. Riches Z, Stanley EL, Bloomer JC, and Coughtrie MW (2009b) Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie." Drug Metab Dispos 37:2255-2261.
31. Sakamoto A, Matsumaru T, Ishiguro N, Schaefer O, Ohtsuki S, Inoue T, Kawakami H, and Terasaki T (2011) Reliability and robustness of simultaneous absolute quantification of drug transporters, cytochrome P450 enzymes, and Udp-glucuronosyltransferases in human liver tissue by multiplexed MRM/selected reaction monitoring mode tandem mass spectrometry with nano-liquid chromatography. J Pharm Sci 100:4037-4043.
32. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423. (Pubitemid 24229655)
33. Skerra A and Plückthun A (1988) Assembly of a functional immunoglobulin-Fv fragment in Escherichia coli. Science 240:1038-1041.
34. Strassburg CP, Kneip S, Topp J, Obermayer-Straub P, Barut A, Tukey RH, and Manns MP (2000) Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 275:36164-36171.
35. Taskinen J, Ethell BT, Pihlavisto P, Hood AM, Burchell B, and Coughtrie MW (2003) Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models. Drug Metab Dispos 31:1187-1197. (Pubitemid 37048291)
36. Thomas NL and Coughtrie MW (2003) Sulfation of apomorphine by human sulfotransferases: evidence of a major role for the polymorphic phenol sulfotransferase, SULT1A1. Xenobiotica 33:1139-1148. (Pubitemid 37500170)
37. Towbin H, Staehelin T, and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354. (Pubitemid 9256559)
38. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616. (Pubitemid 30340694)
39. Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, et al. (2004) Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281-290. (Pubitemid 38263885)